Are BRCA1- and BRCA2-associated breast cancers different?

Journal of Clinical Oncology

Volumn 18, Issue 21 SUPPL., 2000, Pages

  Offit, K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; DNA REPAIR; GENE MUTATION; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; GENES, BRCA1; HUMANS; NEOPLASM PROTEINS; TRANSCRIPTION FACTORS;

EID: 0034329344     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Targeted mutations of breast cancer susceptibility gene homologs in mice: Lethal phenotypes of BRCA1, BRCA2, BRCA1/BRCA2, BRCA1/p53, and BRCA2/p 53 nullizygous embryos
2. Embryonic lethality and radiation hypersensitivity mediated by Rad 51 in mice lacking BRCA2
3. Requirement of ATM-dependent phosphorylation of Brcal in the DNA damage response to double strand breaks
4. Hereditary ovarian cancer: Molecular genetics and clinical implications
5. Association of BRCA 1 with Rad51 in mitotic and meiotic cells
6. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA 1 exon 11 isoform deficient cells
7. BRCA 1 is a component of the RNA polymerase II holoenzyme
8. BRCA 1 protein is linked to the RNA polymerase II holoenzyme complex via helicase A
9. BRCA1 is a cell cycle-regulated nuclear phosphoprotein
10. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA 1
11. BRCA1 required for transcription-coupled repair of oxidative DNA damage
12. Genetic prognostic markers for colorectal cancer